Hi,  welcome to EN-CPhI.cn  Sign In Join Free For Buyer

Search Inquiry Cart (0)
Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd.
You are here: Home >> Marketing Website>> Company Profile
  • Our Company
  • Year Established: 1989

  • Total Annual Sales(USD): More than 1000,000,000

  • Total Number of Staff: more than 500

  • Main Competitive Advantages:

  • Other Competitive Advantages:

  • Patents and Copyrights:

  • Our Business
  • Business Type: Manufacturer,Trading Company

  • Annual Sales(USD): More than 1000,000,000

  • Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Major Product Categories: Active Pharmaceutical Ingredients , Intermediates , Finished Dosage

  • All Products: Active Pharmaceutical Ingredients; Intermediates; Finished Dosage.

  • Product Export Percentage: 9

  • Product Domestic Sale Percentage: 1

  • Main Clients' Names:

  • Other Information
  • Contract Manufacturing

  • Payment Terms

Company Profile

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003.

Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center".

Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D.

The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.


Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989; the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003; API product lisinopril condensation compound through the FDA certification with zero defect in April 2004; Company production through the US FDA certification, becoming the first domestic agents through the certification of the pharmaceutical enterprises in June 2007;  The annual 10 billion export formulations industrial projects was approved by the board of directors in Dec 2008;

Last Updated: Apr 8, 2018 Add as my favorite supplier Abuse Report Product Alert
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved). ICP 05034851-53